Proton magnetic resonance spectroscopy reveals central neuroaxonal impairment in systemic sclerosis

Journal of Rheumatology

Volumn 33, Issue 3, 2006, Pages 546-551

  Bertinotti, Luca ^a   Mortilla, Marzia ^b   Conforti, Maria Letizia ^a   Colangelo, Nicola ^a   Nacci, Francesca ^a   Del Rosso, Angela ^a   Fonda, Claudio ^b   Casale, Roberto ^c   Matucci Cerinic, Marco ^a,d   Pignone, Alberto ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c IRCCS   (Italy)

^d Geriatric Department   (Italy)

Author keywords

Central nervous system; Neurometabolic alterations; Proton magnetic resonance spectroscopy; Systemic sclerosis

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BASAL GANGLION; BRAIN; BRAIN DAMAGE; BRAIN METABOLISM; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEUROAXONAL DYSTROPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SYSTEMIC SCLEROSIS;

ADULT; ASPARTIC ACID; AXONS; BIOLOGICAL MARKERS; BRAIN; CHOLINE; CREATINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED;

EID: 33644672477     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Matucci-Cerinic M, Generini S, Pignone A, Casale R. The nervous system in systemic sclerosis (scleroderma). Clinical features and pathogenetic mechanisms. Rheum Dis Clin North Am 1996;22:879-92.
2. Bertinotti L, Bracci S, Nacci F, et al. The autonomic nervous system in systemic sclerosis. A review. Clin Rheumatol 2004;23:1-5.
3. Casale R, Frazzitta G, Fundaro C, et al. Blink reflex discloses CNS dysfunction in neurologically asymptomatic patients with systemic sclerosis. Clin Neurophysiol 2004;115:1917-20.
4. Ferraccioli G, Di Poi E, Di Gregorio F, Giacomuzzi F, Guerra U. Changes in regional cerebral blood flow after a cold hand test in systemic lupus erythematosus patients with Raynaud's syndrome. Lancet 1999;354:2135-6.
5. Shulman RG, Blamire AM, Rothman DL, McCarthy G. Nuclear magnetic resonance imaging and spectroscopy of human brain function. Proc Natl Acad Sci USA 1993;90:3127-33.
6. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
7. Bombardieri S, Medsger TA Jr, Silman AJ, Valentini G. The assessment of the patient with systemic sclerosis. Introduction. Clin Exp Rheumatol 2003;21 Suppl 29:52-4.
8. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000;27:155-60.
9. De Stefano N, Narayanan S, Francis GS, et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 2001;58:65-70.
10. Dierckx RA, Aichner F, Gersterbrand F, Fritsch P. Progressive systemic sclerosis and nervous system involvement. Eur Neurol 1987;26:134-40.
11. Hietaharju A, Jaaskelainen S, Hietarinta M, Frey H. Central nervous system involvement and psychiatric manifestations in systemic sclerosis (scleroderma): clinical and neurophysiological evaluation. Acta Neurol Scand 1993;87:382-7.
12. Sardanelli F, Iozzelli A, Cotticelli B, et al. White matter hyperintensities on brain magnetic resonance in systemic sclerosis. Ann Rheum Dis 2005;64:777-9.
13. Nobili F, Cutolo M, Sulli A, et al. Impaired quantitative cerebral blood flow in scleroderma patients. J Neurol Sci 1997;152:63-71.
14. Cutolo M, Nobili F, Sulli A, et al. Evidence of cerebral hypoperfusion in scleroderma patients. Rheumatology Oxford 2000;39:1366-73.
15. Bjartmar C, Battistuta J, Terada N, Dupree E, Trapp BD. N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve. Ann Neurol 2001;51:51-8.
16. Tartaglia MC, Narayanan S, De Stefano N, et al. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. J Neurol 2002;249:1382-90.